Healthcare Economics & Policy

IBM Watson Health has announced a new 10-year, $50 million investment in joint research collaboration projects with Brigham and Women’s Hospital in Boston and Vanderbilt University Medical Center (VUMC) to advance the application of artificial intelligence (AI) in public health.

Zebra Medical Vision announced it has received grants from the Israel Innovation Authority to implement its AI algorithms in three of Israel's largest medical institutions.

Strategic Radiology announced Thursday, Feb. 14, that Asheville, North Carolina-based Asheville Radiology Associates (ARA) has joined the company’s coalition of independent radiology practices.

Kai-Fu Lee, the CEO of a Chinese venture capital firm and former president of Google China, discussed AI and its impact on various sectors of the economy in a new interview with Fox Business.

When CNBC put together a list of in-demand jobs that pay more than $55,000 a year and only require an associate’s degree, most of those jobs were in healthcare—and many involved medical imaging.  

RadNet announced Monday, Feb. 11, that it has signed a definitive agreement to acquire Kern Radiology Medical Group, a Bakersfield, California-based outpatient radiology practice that owns five imaging centers.

The precision medical imaging market is expected to grow from $120 million in 2017 to more than $8 billion in 2027, according to new analysis from Frost & Sullivan.

According to a new ranking from Forbes, AI and its ability to help radiologists streamline image analysis represents the No. 1 digital health technology of 2019.

In Arkansas, money from a tobacco tax is allocated to breast cancer research, but how are those funds spent? 

Companies developing imaging solutions powered by AI raised nearly $580 million in 2018, according to a report from Signify Research.

GT Medical Technologies (GT MedTech) has raised $10 million in Series A funding to help support the launch of GammaTile Therapy, the company’s FDA-cleared radiation treatment developed for patients with recurrent brain tumors.

General Electric (GE) has changed its original strategy and will now aim to sell nearly half of its healthcare unit, GE Healthcare, according to GE CEO Larry Culp.